Vascular Inflammation in Psoriasis - Apremilast

Clinical trial NCT03082729 · COMPLETED

Trial details

NCT number: NCT03082729
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Cardiovascular Diseases

Start date: 2017-04-24
Primary completion: 2021-08-17
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.